title: Fluoride incorporation into apatite crystals delays amelogenin hydrolysis.
abstract: Enamel fluorosis has been related to an increase in the amount of amelogenin in fluorosed enamel compared with normal enamel in the maturation stage. In this study we tested the hypothesis that fluoride incorporated into carbonated apatite alters amelogenin hydrolysis. Recombinant human amelogenin (rh174) was allowed to bind to 0.15 mg of carbonated hydroxyapatite (CAP) or to fluoride-containing carbonated hydroxyapatite (F-CAP) synthesized to contain 100, 1,000, or 4,000 ppm F(-). After 3 h of digestion with recombinant human matrix metalloproteinase 20 (MMP20) or kallikrein-related peptidase 4 (KLK4), bound protein was characterized by reverse-phase high-performance liquid chromatography (HPLC). Proteolytic fragments of amelogenin formed after 24h of digestion with MMP20 of KLK 4 were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The hydrolysis, by both MMP20 and KLK4, of amelogenin bound to F100-CAP was significantly reduced in a dose-dependent manner compared with the hydrolysis of amelogenin bound to CAP. After 24 h of hydrolysis, a similar number of MMP20 cleavage sites was found for amelogenin bound to CAP and amelogenin bound to F100-CAP; however, 24 fewer KLK4 cleavage sites were identified for amelogenin bound to F100-CAP than for amelogenin bound to CAP. These results suggest that the reduced hydrolysis of amelogenins in fluorosed enamel may be partially caused by the increased fluoride content in fluoride-containing apatite, contributing to the hypomineralized enamel matrix phenotype observed in fluorosed enamel.
authors.affiliation: Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, CA 94143-0422, USA. pamela.denbesten@ucsf.edu
authors.forename: Pamela K
authors.initials: PK
authors.lastname: DenBesten
authors.forename: Li
authors.initials: L
authors.lastname: Zhu
authors.forename: Wu
authors.initials: W
authors.lastname: Li
authors.forename: Kotaro
authors.initials: K
authors.lastname: Tanimoto
authors.forename: Haichuan
authors.initials: H
authors.lastname: Liu
authors.forename: Halina E
authors.initials: HE
authors.lastname: Witkowska
mesh_terms: D053523:Amelogenin / Q000187:drug effects / Q000378:metabolism*; D001031:Apatites / Q000378:metabolism*; D002853:Chromatography, Liquid; D003743:Dental Enamel / Q000378:metabolism*; D003744:Dental Enamel Hypoplasia / Q000378:metabolism; D005459:Fluorides / Q000009:adverse effects* / Q000493:pharmacokinetics*; D009050:Fluorosis, Dental / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D007610:Kallikreins / Q000378:metabolism; D053519:Matrix Metalloproteinase 20 / Q000378:metabolism; D011485:Protein Binding; D059748:Proteolysis; D011994:Recombinant Proteins / Q000378:metabolism; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D053523:Amelogenin; D001031:Apatites; D011994:Recombinant Proteins; C030782:carboapatite; D007610:Kallikreins; C120801:kallikrein 4; D053519:Matrix Metalloproteinase 20; C025105:fluorapatite; D005459:Fluorides